The ten-slide pattern still works
The Sequoia Capital pitch-deck template, published in the early 2010s and still the global reference for early-stage decks, prescribes ten slides: Title, Company Purpose, Problem, Solution, Why Now, Market Size, Competitors, Product, Business Model, and Team. Most successful pitch decks across the last decade have varied this structure by no more than one or two slides.
Paul Graham, the co-founder of Y Combinator, frames the same problem from the writing side. The investor reads the deck for thirty seconds before deciding whether to take the meeting. Every slide that does not have a single, sharp, falsifiable claim costs you the meeting. Graham's essays "How to Present to Investors" and "How to Raise Money" remain the clearest writing on the subject.
The clinician's instinct that breaks the deck
Clinician founders consistently lead the deck with the clinical problem. The instinct is correct in clinical communication. It is wrong in investor communication.
The investor is not a clinician and is not buying clinical insight. They are underwriting a company. The clinical problem belongs in the deck, but it belongs after the dollar figure (the cost of the problem to the buyer) and after the buyer (who pays). The first three slides of a clinician-led pitch deck should read like an enterprise SaaS deck, with clinical context appearing only after slide five.
This single restructure is the most common feedback clinician founders receive when they show their deck to a non-clinical investor for the first time. Run the test before the meeting. Ask a non-clinician whether the first three slides made them want to read the next seven.
The customer-evidence slide is the one that actually proves anything
Investors will forgive a weak market slide. They will not forgive a weak customer slide. Most clinician-led decks underweight customer evidence in favour of clinical evidence (publications, regulatory pathway, KOL endorsements). Both matter. The investor pays for the first.
What goes on the customer-evidence slide. Two anonymised case studies with a numeric outcome. A short quote from a buyer (CFO, CMO, practice owner) rather than from a clinician user. Cohort retention or a comparable usage metric. If you do not have the numbers yet, the question to answer at the meeting is what data you would need to collect over the next six months to populate the slide.
The team slide problem
Clinician founders typically over-build the team slide. Four resumes, three of them clinical, two with overlapping skill sets. Investors at seed and Series A read this as a startup that has not figured out who actually does what.
The cleaner pattern is one founder, one named technical lead, and the named first commercial hire if they exist. Other clinical advisors belong on a separate "Clinical and scientific" slide later in the deck, or in an appendix. The investor's mental cost of evaluating four resumes on slide two is significantly higher than the cost of evaluating one clear founder narrative.
Five mistakes to avoid
Burying the dollar figure. The cost of the problem to the buyer should be on slide three, in a font size that is unmissable. If the dollar figure is not concrete, the deck is not finished.
Putting the clinical mechanism before the buyer. Slide four is the buyer. Slide five at the earliest is the mechanism. Reverse the order and the deck reads like a research paper.
Pitching the wrong segment. "Healthcare" is not a market. The market is the named buyer (independent GP practice, public tertiary hospital, private health insurer) at a specific price band. Decks that fail to declare the segment lose the meeting on slide six.
A 50-slide appendix. Paul Graham's rule. Decks longer than fifteen slides do not get read. The appendix is for the data room, not the meeting.
No ask. The final slide must include the round size, the use of funds in three lines, and the named lead you are looking for. Decks without an ask end with the investor unsure what you are asking them for, and the meeting drifts.
Sources
Written by ASME Editorial · Published 29 Apr 2026